For 59% of women, the post-menopausal years bring a physical burden that is far from anecdotal: chronic joint pain.
A meta-analysis of 37 studies encompassing 93,000 women, cited by ICI, reveals that this discomfort often predates the final transition, affecting 40% of women before menopause and 57% during perimenopause.
The primary driver is a precipitous drop in estrogen. While this hormonal shift does not trigger pain directly, it destabilizes a complex physiological ecosystem, leading to systemic inflammation, accelerated bone density loss, and diminished muscle strength, midwife Anna Roy explained in the podcast Hot flashes.
Not every ache at age 50 is a byproduct of hormonal transition. Clinicians warn that persistent or localized pain demands investigation to rule out underlying pathology.
“A persistent, unusual pain must lead to searching for something else,” Roy said to ICI.
Dr. Vlad noted in the Neighbors’ Journal that patients often misattribute pain in small joints, elbows, or shoulders to work posture rather than hormonal fluctuations. For patients like Amélia, identifying the link between these physical changes and the menopause transition provides a vital sense of agency.
When joints ache, the instinct is to rest.
“Systematically putting a painful joint to rest risks, on the contrary, leading to a vicious cycle,” Roy said to ICI.
Instead, she advocates for low-impact movement—swimming, cycling, walking, Pilates, or yoga—to reclaim mobility.
“At menopause, you must not only do ‘gentle sport’ because what we want to protect at the same time as the joints is the muscle and the bone,” Roy said to ICI.
Progressive muscle resistance is critical for long-term health, yet many women remain underserved. The Neighbors’ Journal reported that many women rely on social circles rather than medical professionals for information, fueling isolation and misinformation.
Medical associations like Lëtz Menopause Asbl are pushing for earlier intervention during perimenopause, Dr. Susanne Folschette told RTL Luxembourg. Their position is clear: menopause is a biological stage, not a mandate to accept a diminished quality of life.
Hormone therapy remains a potent, if debated, tool for symptom relief and bone density preservation. Despite its utility, uptake remains remarkably low; West France reported that in 2022, only 6% of women utilized such treatments.
Keep reading